New Strong Sell Stocks for October 4th

The Wall Street Journal
One Supreme Court Case Could Mess Up Chunks of the Tax Code
WASHINGTON—A case that could punch holes in the federal tax code heads to the Supreme Court on Tuesday. The court will hear arguments in Moore v. U.S., which challenges a piece of the 2017 tax law that imposed a one-time levy on profits that companies had accumulated outside the U.S. But its implications could reach much further, providing the justices an opportunity to define what Congress can tax under the Constitution—and what it can’t. Charles and Kathleen Moore argue that when the law passed, they hadn’t realized income from their investment in an India-based company and thus couldn’t be taxed.
1d ago
Barrons.com
Palantir Stock Has Soared This Year. This Issue Could Stop Its Run.
Palantir Technologies shares have soared on excitement for artificial intelligence. But one worry could limit the analytics-software firm’s future gains, according to William Blair analysts.
3h ago
SmartAsset
I Want to Convert $500k in My 401(k) to a Roth IRA. How Do I Avoid Paying Taxes?
You can't avoid taxes when making a Roth IRA conversion, but there are strategies to reduce your tax burden if the circumstances are right. When you convert money from a pre-tax account, such as a 401(k) or an IRA, to a post-tax Roth IRA, you must pay income taxes on the full value of the […] The post I Want to Convert $500k in My 401(k) to a Roth IRA. How Do I Avoid Paying Taxes? appeared first on SmartReads by SmartAsset.
6h ago
SmartAsset
Forget About ‘Timing the Market': Schwab Research Reveals the Optimal Way to Invest
Can investors realistically time the market to maximize returns, especially over the long term? According to a recent study from Charles Schwab, perfect market timing is practically impossible. The firm’s research showed that most investors are better off investing as soon as possible using a buy-and-hold strategy rather than trying to predict short-term peaks and […] The post Forget About ‘Timing the Market’: Schwab Research Reveals the Optimal Way to Invest appeared first on SmartReads by Smar
1d ago
Benzinga
'Rich Dad Poor Dad' Author Robert Kiyosaki Says 'Only Lazy People Use Their Own Money' — Why You Should Use Other People's Money Instead
Robert Kiyosaki, renowned for his bestselling book “Rich Dad Poor Dad,” advocates a provocative approach to wealth accumulation, stating, “My rich dad always said only lazy people use their own money.” This philosophy underpins Kiyosaki’s success in transforming negligible funds into substantial returns. Contrary to conventional wisdom, he emphasizes the importance of not using your own money for investments but instead leveraging other people’s money (OPM). Kiyosaki’s strategy involves innovati
56m ago
SmartAsset
Ask an Advisor: I'm 67 with $750K in a 401(k). How Can I Preserve This Money for the Rest of My Life?
I am in a quandary about how to invest $750,000 that’s in my 401(k). I'm 67 years old, retired and I have not started taking Social Security yet. What is the best way to preserve this money for the rest of my life that doesn't have high fees? -Terry As you know, the big challenge […] The post Ask an Advisor: I’m 67 with $750K in a 401(k). How Can I Preserve This Money for the Rest of My Life? appeared first on SmartReads by SmartAsset.
1d ago
TipRanks
Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to Take Advantage
A key to success in the stock market is a touch of foresight. Not quite precognition, but an ability to spot and put together clues and trends, to discern the ‘next big thing’ before it hits. This is true in every stock sector, but today we’ll focus on biotech. The biotech firms have famously high product lead times, paired with equally high overhead expenses; it’s a combination that would make them unlikely investments, except that when a drug is approved, it can turn into a blockbuster. Succes
21h ago
Investor's Business Daily
Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data
Shares in Alterity Therapeutics soared after the biotech firm disclosed promising new clinical trial data for its Parkinson's disease treatment.
2h ago
Fox Business
IRS move could carry hefty cost for some taxpayers
The IRS is raising the interest penalty for underpayment of estimated taxes, with taxpayers who are self-employed or work as independent contractors urged to be vigilant.
18h ago
Zacks
Alibaba Group Holding Limited (BABA) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Alibaba (BABA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
4h ago
Barrons.com
This Ohio City Is Next Year’s Hottest Place to Live
Some Midwestern and Northeastern housing markets will likely see growth in 2024 in healthcare and manufacturing, Realtor.com says.
4h ago
Zacks
Are Options Traders Betting on a Big Move in Affirm Holdings (AFRM) Stock?
Investors need to pay close attention to Affirm Holdings (AFRM) stock based on the movements in the options market lately.
4h ago
The Wall Street Journal
Beyoncé’s ‘Renaissance’ Tops U.S. Box Office With $21 Million in Sales
The concert film outperformed competitors on its opening weekend but couldn’t match the box office of Taylor Swift’s film debut.
21h ago
News Direct
BestGrowthStocks.Com Issues Comprehensive Analysis of the Recent Hut 8 Mining Corp. Merger
Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issu...
5h ago
Barrons.com
Gold Prices Drop Back After Record High. What’s Next for the Precious Metal.
Gold prices dropped back from record highs early on Monday. Some analysts are skeptical of further gains.
4h ago
Yahoo Finance
Virgin Galactic stock tanks after Richard Branson signals no more investments
Virgin Galactic stock saw its biggest drop since June after founder Richard Branson said he won't be giving the company any more money.
3h ago
Bloomberg
Analyst Who Called Chinese Bank Turmoil Says Trusts Are Next
(Bloomberg) -- The analyst who predicted the troubles that cascaded through China’s regional banks four years ago now has a similar warning for the nation’s $2.9 trillion trust industry. Most Read from BloombergHow Suspects Laundered Billions in Singapore for YearsBonds, Stocks in Retreat as Rate Realism Seeps In: Markets WrapBitcoin Surges Past $42,000 as Crypto Rally Gathers SteamHere’s How to Invest in Gold as It Hits an All-Time HighAlaska Air Agrees to Buy Hawaiian in $1.9 Billion DealMany
18h ago
Fortune
Soaring mortgage rates hit U.S. cities: Here’s where buying a home is most expensive relative to renting
As the Fed fights inflation, the gap between the cost of home ownership and the cost of renting has reached an unprecedented high.
19h ago
Barrons.com
Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It’s Hoping to Compete with Eli Lilly, Novo Nordisk.
Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion. The Swiss company is hoping to join Eli Lilly and Novo Nordisk at the forefront of the weight-loss drug market.
2h ago
Zacks
Gold ETF (GLD) Hits New 52-Week High
This gold ETF hits a new 52-week high. Are more gains in store for this ETF?
4h ago

S&P 500

Dow 30

Nasdaq

Russell 2000

Crude Oil

Gold

Silver

EUR/USD

10-Yr Bond

GBP/USD

USD/JPY

Bitcoin USD

CMC Crypto 200

FTSE 100

Nikkei 225

New Strong Sell Stocks for October 4th

Recommended Stories

One Supreme Court Case Could Mess Up Chunks of the Tax Code

Palantir Stock Has Soared This Year. This Issue Could Stop Its Run.

I Want to Convert $500k in My 401(k) to a Roth IRA. How Do I Avoid Paying Taxes?

Forget About ‘Timing the Market': Schwab Research Reveals the Optimal Way to Invest

'Rich Dad Poor Dad' Author Robert Kiyosaki Says 'Only Lazy People Use Their Own Money' — Why You Should Use Other People's Money Instead

Ask an Advisor: I'm 67 with $750K in a 401(k). How Can I Preserve This Money for the Rest of My Life?

Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to Take Advantage

Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data

IRS move could carry hefty cost for some taxpayers

Alibaba Group Holding Limited (BABA) is Attracting Investor Attention: Here is What You Should Know

This Ohio City Is Next Year’s Hottest Place to Live

Are Options Traders Betting on a Big Move in Affirm Holdings (AFRM) Stock?

Beyoncé’s ‘Renaissance’ Tops U.S. Box Office With $21 Million in Sales

BestGrowthStocks.Com Issues Comprehensive Analysis of the Recent Hut 8 Mining Corp. Merger

Gold Prices Drop Back After Record High. What’s Next for the Precious Metal.

Virgin Galactic stock tanks after Richard Branson signals no more investments

Analyst Who Called Chinese Bank Turmoil Says Trusts Are Next

Soaring mortgage rates hit U.S. cities: Here’s where buying a home is most expensive relative to renting

Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It’s Hoping to Compete with Eli Lilly, Novo Nordisk.

Gold ETF (GLD) Hits New 52-Week High